The unexpected consequences of generic entry
Year of publication: |
2019
|
---|---|
Authors: | Castanheira, Micael ; Ornaghi, Carmine ; Siotis, Georges |
Published in: |
Journal of health economics. - Amsterdam [u.a.] : Elsevier, ISSN 0167-6296, ZDB-ID 625797-5. - Vol. 68.2019, p. 1-22
|
Subject: | Non-price competition | Pharmaceutical industry | Generic entry | Consumer choice | Pharmaindustrie | Generika | Generic drugs | Markteintritt | Market entry | Konsumentenverhalten | Consumer behaviour | Arzneimittel | Pharmaceuticals | Nichtpreiswettbewerb | Preiswettbewerb | Price competition |
-
The unexpected consequences of generic entry
Castanheira, Micael, (2019)
-
Olson, Luke M., (2013)
-
Competition between generic and brand name drugs : new evidence from the U.S. pharmaceutical market
Cavaliere, Alberto, (2022)
- More ...
-
The unexpected consequences of asymmetric competition : an application to big pharma
Castanheira, Micael, (2017)
-
Market definition in the pharmaceutical industry : a case of drugs hopping antitrust markets?
Ornaghi, Carmine, (2019)
-
Market definition and competition policy enforcement in the pharmaceutical industry
Siotis, Georges, (2020)
- More ...